FABP7P2

Across TCGA pan-cancer cohorts, FABP7P2 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated FABP7P2 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher FABP7P2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated FABP7P2 expression acts as an unfavorable survival marker, although some lineages such as ACC and LAML show a favorable association.

BLCA, LUSC, and ACC are the cancer types where FABP7P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	All	0.136	0.603	<.001	45	view →
LUSC	OS	Tertile	IV	0.001	0.673	.014	36	view →
ACC	OS	Tertile	IV	0.886	0.307	.013	30	view →
CHOL	DFS	Tertile	II,III,IV	0.100	0.422	.033	27	view →
BRCA	DFS	Tertile	All	0.861	0.908	.013	24	view →
UVM	DFS	Tertile	II,III,IV	0.422	0.631	.028	18	view →
MESO	OS	Tertile	All	0.315	0.574	.013	18	view →
LAML	DFS	Tertile	All	0.657	0.317	.034	18	view →
ESCA	OS	Quartile	All	0.431	0.597	.017	16	view →
SKCM	OS	Tertile	IV	0.133	0.621	.019	14	view →
GBM	DFS	Tertile	All	0.409	0.210	.017	12	view →
STAD	OS	Tertile	IV	0.642	0.203	.006	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

FABP7P2–BLCA (DFS)

Open the BLCA breakdown →